Evidence map›Paper›PMID 33050630›Full record

ArticleJournal of clinical medicine2020

Mindfulness-Based Program Plus Amygdala and Insula Retraining (MAIR) for the Treatment of Women with Fibromyalgia: A Pilot Randomized Controlled Trial.

Juan P Sanabria-Mazo, Jesus Montero-Marin, Albert Feliu-Soler, Virginia Gasión, Mayte Navarro-Gil, Héctor Morillo-Sarto, Ariadna Colomer-Carbonell, Xavier Borràs, Mattie Tops, Juan V Luciano and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review of Fibromyalgia (FM) Syndrome Treatments.International journal of environmental research and public health · 2022
    Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 3 countries.

Juan P Sanabria-MazoInstitut de Recerca Sant Joan de Déu, Esplugues de Llobregat, 08950 Barcelona, Spain.ORCID 0000-0003-1688-435X
Jesus Montero-MarinDepartment of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX, UK.ORCID 0000-0001-5677-1662
Albert Feliu-SolerInstitut de Recerca Sant Joan de Déu, Esplugues de Llobregat, 08950 Barcelona, Spain.ORCID 0000-0003-2810-7670
Virginia GasiónInstituto de Investigación Sanitaria Aragón, Hospital Universitario Miguel Servet, 50009 Zaragoza, Spain.
Mayte Navarro-GilInstituto de Investigación Sanitaria Aragón, Hospital Universitario Miguel Servet, 50009 Zaragoza, Spain.
Héctor Morillo-SartoBasic Psychology Department, Faculty of Psychology, University of Zaragoza, 44003 Teruel, Spain.
Ariadna Colomer-CarbonellInstitut de Recerca Sant Joan de Déu, Esplugues de Llobregat, 08950 Barcelona, Spain.ORCID 0000-0001-8923-6316
Xavier BorràsFaculty of Psychology, Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), 08193 Barcelona, Spain.ORCID 0000-0003-3972-1385
Mattie TopsDevelopmental and Educational Psychology Unit, Leiden University, 233 AK Leiden, The Netherlands.
Juan V LucianoInstitut de Recerca Sant Joan de Déu, Esplugues de Llobregat, 08950 Barcelona, Spain.ORCID 0000-0003-0750-1599
Javier García-CampayoInstituto de Investigación Sanitaria Aragón, Hospital Universitario Miguel Servet, 50009 Zaragoza, Spain.ORCID 0000-0002-3797-4218
Universitat Autònoma de Barcelona · ESRed de Investigación en Actividades Preventivas y Promoción de la Salud · ESHospital Universitario Miguel Servet · ESLeiden University · NLSant Joan de Déu Research Foundation · ESUniversidad de Zaragoza · ESWarneford Hospital · GB

Funding

Instituto de Salud Carlos III CPII19/00003Wellcome Trust 104908/Z/14/Z/
6 · The paper itself

Abstract

The lack of highly effective treatments for fibromyalgia (FM) represents a great challenge for public health. The objective of this parallel, pilot randomized controlled trial (RCT) was two-fold: (1) to analyze the clinical effects of mindfulness plus amygdala and insula retraining (MAIR) compared to a structurally equivalent active control group of relaxation therapy (RT) in the treatment of FM; and (2) to evaluate its impact on immune-inflammatory markers and brain-derived neurotrophic factor (BDNF) in serum. A total of 41 FM patients were randomized into two study arms: MAIR (intervention group) and RT (active control group), both as add-ons of treatment as usual. MAIR demonstrated significantly greater reductions in functional impairment, anxiety, and depression, as well as higher improvements in mindfulness, and self-compassion at post-treatment and follow-up, with moderate to large effect sizes. Significant decreases in pain catastrophizing and psychological inflexibility and improvements in clinical severity and health-related quality of life were found at follow-up, but not at post-treatment, showing large effect sizes. The number needed to treat was three based on the criteria of ≥50% Fibromyalgia Impact Questionnaire (FIQ) reduction post-treatment. Compared to RT, the MAIR showed significant decreases in BDNF. No effect of MAIR was observed in immune-inflammatory biomarkers (i.e., TNF-α, IL-6, IL-10, and hs-CRP). In conclusion, these results suggest that MAIR, as an adjuvant of treatment-as-usual (TAU), appears to be effective for the management of FM symptoms and for reducing BDNF levels in serum.

Indexed as

amygdala and insula retrainingbrain-derived neurotrophic factorfibromyalgiaimmune-inflammatory markersmind–body techniquesmindfulnessmulticomponent interventionpilot studyrandomized controlled trial

Identifiers

PMID33050630
PMCPMC7599726
OpenAlexW3092092669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.